Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyTue, 16 Jul 2024 06:38:39 +0200Wed, 20 Mar 2024 11:13:00 +0100Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of authorisation: 17/03/2008, Revision: 42, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/pradaxaHuman medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Date of authorisation: 17/03/2008, Revision: 42, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/pradaxaWed, 20 Mar 2024 11:13:00 +0100Human medicinePradaxa : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0829-steps-after_en_0.pdfPradaxa : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0829-steps-after_en_0.pdfTue, 16 Jan 2024 16:08:00 +0100Human medicine